The present invention relates to a method for screening maternal urine samples for changes in the pattern of mass spectral fingerprinting which have been found to be characteristic of fetal aneuploidies such as Down's Syndrome and have application for the5 screening of other fetal abnormalities and disorders of pregnancy including gestational trophoblastic diseases.
